Completed PHASE3 INTERVENTIONAL NCT00002654

Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Head and Neck Cancer

Phase III Study of Hyperfractionated Radiation Therapy With or Without Simultaneaous Application of CIS-Platinum in Patients With Moderately Advanced to Advanced Cancers of the Head and Neck

Sponsor: Swiss Cancer Institute

Conditions Head and Neck Cancer

Interventions chemotherapy cisplatin low-LET cobalt-60 gamma ray therapy low-LET electron therapy low-LET photon therapy

Updated 7 times since 2017 Last updated: May 13, 2019 Started: Apr 30, 1994 Primary completion: Mar 31, 1999 Completion: Jul 31, 2000

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00002654, this PHASE3 trial focuses on Head and Neck Cancer and remains completed. Sponsored by Swiss Cancer Institute, it has been updated 7 times since 1994, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

7 versions recorded

Aug 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Aug 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2019 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Jun 2018 — Jun 2019 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Apr 1994

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Swiss Cancer Institute

Data source: Swiss Cancer Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zurich, Switzerland